Press Releases

Date	Title	Company
20-Sep-2022	Rare Hematology Market Growth CAGR of 5.26%, Restraints, Mergers And Forecast (2022-2031)	Wired Release
20-Sep-2022	Body Contouring Devices Market to Record a CAGR of 14.4%, Hospitals and Clinics to be Largest Revenue-generating Application Segment – Market.us	Wired Release
20-Sep-2022	6.5% CAGR of Angiography System Market — North America to dominate market growth	Wired Release
20-Sep-2022	Automatic Immunoassay Analyzer Market Will Accelerate at a CAGR of over 11.1% through 2022-2031	Wired Release
20-Sep-2022	Surgical Hemostats Market SWOT analysis and Key Business Strategies, Demand and Forecast by 2031	Wired Release
20-Sep-2022	Prenatal Testing Market Size Worth USD 9.12 Billion by 2028 \| Market.us	Wired Release
20-Sep-2022	Oxygen Masks Market Globally Expected to Drive Growth [+Net Income] \| 2022-2031	Wired Release
20-Sep-2022	Synaffix Wins ‘Best ADC Platform Technology’ Award Again at World ADC Awards Ceremony 2022	Synaffix
20-Sep-2022	As polio threatens a return, UK expert calls for extensive antibody testing to protect vulnerable communities	London Medical Laboratory
20-Sep-2022	Immutep Clinical Development Update for its First-in-Class LAG-3 Antigen Presenting Cell Activator Candidate Eftilagimod Alpha	Immutep
20-Sep-2022	Minoryx‘s marketing authorization application for its lead candidate leriglitazone validated by EMA for orphan indication X-linked adrenoleukodystrophy (X-ALD)	Minoryx
20-Sep-2022	Almirall: Tildrakizumab is the first and only IL-23p19 inhibitor to demonstrate meaningful sleep improvement in people living with psoriasis	Almirall
20-Sep-2022	Aleva Neurotherapeutics SA Announces MRI Approval for its directSTIM™ Deep Brain Stimulation System	Aleva Neurotherapeutics SA
20-Sep-2022	New Study Reveals First Genetic Links in ME and Chronic Fatigue Syndrome Paving the Way for New Diagnostics and Drugs	PrecisionLife
20-Sep-2022	Positive Solutions and Charac announce exclusive strategic partnership	Charac
20-Sep-2022	Coave Therapeutics to Collaborate with World-Renowned Institute of Neurodegenerative Diseases of Bordeaux to Develop Gene Therapy Programs Targeting Protein Degradation in Neurodegenerative Disorders	Coave Therapeutics
20-Sep-2022	Covalab, CimCure and partners receive €1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma	Andrew Lloyd Associates
20-Sep-2022	Covalab, CimCure and partners receive €1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma	Andrew Lloyd Associates
20-Sep-2022	Cryogenic Vials Market Strategies [+Sales Growth], Factors and Forecast 2031	Wired Release
20-Sep-2022	Antimicrobial Susceptibility Testing Product Market to record USD 2.4 bn growth, Evolving Opportunities with Bio-Rad (US) and Hi-Media (India)	Wired Release